Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Buisson

Showing results (101-110 of 120) with videos related to

Pageof 12
Sort By:
Advances in Experimental Medicine and Biology|February 23, 1999
Use of the IGF-I antisense strategy in the treatment of the hepatocarcinomaL C Upegui-Gonzalez, H T Duc, Y Buisson, et al.
Vaccine|March 1, 1990
Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virusP Coursaget, B Yvonnet, C Bourdil, et al.
Vaccine|August 1, 1988
Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunizationP Coursaget, P Adamowicz, C Bourdil, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|January 1, 1990
[Markers of viral hepatitis B and D and levels of alanine aminotransferase in military blood donors: a profile of 30,000 blood donations in 1989]G Boulesteix, P Bourin, G Fabre, et al.
Journal of Hepatology|June 8, 2001
Allogenic bone marrow transplantation with a donor presenting with an acute hepatitis AD Ghez, E Nicand, V Ferré, et al.
Research in Virology|September 1, 1990
Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunizationP Coursaget, Y Buisson, C Bourdil, et al.
Pathologie-Biologie|May 1, 1990
[Frequency and distribution of beta-lactamases in 1792 strains of Klebsiella pneumoniae in France between 1985 and 1988]A Thabaut, J Acar, P Allouch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 14, 2004
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and CambodiaJ Chandenier, K D Adou-Bryn, C Douchet, et al.
Epidemiology and Infection|August 30, 2014
Tuberculosis in Laos, who is at risk: the mahouts or their elephants?J Lassausaie, A Bret, X Bouapao, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Sensitivity of Pseudomonas aeruginosa and Klebsiella spp. to ceftazidime. Current status in France]A Thabaut, J Acar, G Arlet, et al.
Pageof 12

Showing results (101-110 of 120) with videos related to

Sort By:
Pageof 12
Advances in Experimental Medicine and Biology|February 23, 1999
Use of the IGF-I antisense strategy in the treatment of the hepatocarcinomaL C Upegui-Gonzalez, H T Duc, Y Buisson, et al.
Vaccine|March 1, 1990
Hepatitis B surface antigen reactivity in man due to a new variant of hepatitis B virusP Coursaget, B Yvonnet, C Bourdil, et al.
Vaccine|August 1, 1988
Anti-pre-S2 antibodies in natural hepatitis B virus infection and after immunizationP Coursaget, P Adamowicz, C Bourdil, et al.
Revue Francaise De Transfusion Et D'Hemobiologie : Bulletin De La Societe Nationale De Transfusion Sanguine|January 1, 1990
[Markers of viral hepatitis B and D and levels of alanine aminotransferase in military blood donors: a profile of 30,000 blood donations in 1989]G Boulesteix, P Bourin, G Fabre, et al.
Journal of Hepatology|June 8, 2001
Allogenic bone marrow transplantation with a donor presenting with an acute hepatitis AD Ghez, E Nicand, V Ferré, et al.
Research in Virology|September 1, 1990
Antibody response to preS1 in hepatitis-B-virus-induced liver disease and after immunizationP Coursaget, Y Buisson, C Bourdil, et al.
Pathologie-Biologie|May 1, 1990
[Frequency and distribution of beta-lactamases in 1792 strains of Klebsiella pneumoniae in France between 1985 and 1988]A Thabaut, J Acar, P Allouch, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|May 14, 2004
In vitro activity of amphotericin B, fluconazole and voriconazole against 162 Cryptococcus neoformans isolates from Africa and CambodiaJ Chandenier, K D Adou-Bryn, C Douchet, et al.
Epidemiology and Infection|August 30, 2014
Tuberculosis in Laos, who is at risk: the mahouts or their elephants?J Lassausaie, A Bret, X Bouapao, et al.
Presse Medicale (Paris, France : 1983)|October 26, 1988
[Sensitivity of Pseudomonas aeruginosa and Klebsiella spp. to ceftazidime. Current status in France]A Thabaut, J Acar, G Arlet, et al.
Pageof 12